🔗 Share this article Social Media Content Creators Fueling Parallel Market for Unlicensed Weight-Loss Drug A shadow market for unapproved slimming drugs is being driven by social media fitness personalities and vendors on messaging platforms, based on new investigations. Experimental Drug Acquiring Popularity Via Social Media The experimental drug, which remains in clinical trials, is being advertised by online personalities for its alleged fat-burning properties. Viewers are urged to message these accounts directly for source information, while also receiving discount codes. Thriving Commerce on Social Networks Separately, a flourishing trade exists on messaging services, where communities with numerous of participants share comparison photos, injection guides and assertions of next-day UK delivery. Sellers market the drug there before redirecting customers to other platforms for purchases. Learning About The Experimental Drug This medication is an investigational injectable developed by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – GLP-1, GIP and glucagon. Preliminary studies suggest it could assist patients reduce up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being promoted digitally as the next Ozempic. Healthcare Professionals Express Worries Nevertheless, doctors and chemists have cautions that the distribution of what remains an unlicensed drug in the UK is a cause for concern and could result in individuals injecting products of unknown origin. Several experts said the demand for the experimental drug could be linked to the rising price of licensed weight loss products such as Mounjaro. Regulatory Position and Enforcement Marketing the unapproved drug on TikTok or Telegram is illegal in the UK, as it is an unapproved medication that must not be promoted or supplied for human use under the Human Medicines Regulations 2012. Some influencers attempt to circumvent the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted substance, but promotion and supply can still breach medicines, advertising, and consumer laws, potentially leading to fines, prosecution or prison. Platform Reaction and Content Removal Based on the social media company, the platform has removed problematic material and prohibited related keywords and search suggestions. The company stated it was committed to maintaining the platform safe and allocating resources in enhancing compliance measures. Online Trading Activities Investigations also discovered groups with up to 9,000 members selling the experimental drug using the platform's built-in search feature, which functions like a online catalog. Entering “retatrutide” instantly brings up groups with thousands of users, filled with images of weight loss, glowing testimonials and detailed instructions for mixing or injecting at home. Within minutes of joining one community, a vendor posted contact information, where the majority of transactions take place. The vendor provided an guidebook and guaranteed delivery within 48 hours. When questioned whether the product was authentic, one vendor said: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. Not one asked about body mass, medical conditions or past usage. Item Details and Costs Within these communities, posts show dark colored parcels with postal service stickers, claiming to include fresh supplies. One communication stated: “It took eight of us to load them this morning.” Buyers can choose between powder vials, mixed at residence with sterile water, or pre-filled pens usually priced at 160 pounds for 20 milligrams. When asked how much time a injector should last, vendors give conflicting answers varying between a several days to “depends on your body”. Service Oversight and Security Actions A spokesperson for the messaging service stated it regularly monitored dangerous content on its platform including content that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”. Medical Expert Warnings “Individuals are injecting substances they can’t verify. Although the research behind this drug is sound, these online versions may not contain what they claim,” said a pharmacy expert, the head of pharmaceutical services at a pharmacy service. Dr Crystal Wyllie of an online medical service linked the increase in interest to current price rises for authorized weight-loss medications such as Mounjaro. “With prices increasing, patients are turning to online platforms. But fake injections are extremely dangerous. You can’t be certain what’s contained or whether the environment they were produced in was sterile,” she said. Her team has previously seen individuals injured by self-injection from unverified suppliers. “We understand the frustration, but purchasing from Telegram or WhatsApp is gambling with your health,” said the doctor. “These substances could be contaminated or incorrectly dosed.” Producer Position A representative from Eli Lilly said the substance was in third stage research studies and had not been reviewed or authorized by any government authority anywhere in the world. “Therefore at this time no one can sell [it] for human use,” they explained, noting that any product “falsely representing itself as a Lilly investigational product not yet authorized … may expose users to possibly significant medical dangers”.